Ignite Creation Date:
2024-05-05 @ 11:30 AM
Last Modification Date:
2024-10-26 @ 9:09 AM
Study NCT ID:
NCT00067730
Status:
COMPLETED
Last Update Posted:
2007-12-07
First Post:
2003-08-25
Brief Title:
A Safety Evaluation of Drotrecogin Alfa Activated in Patients With Blood Cancer Severe Infection Related to Bone Marrow Transplantation
Sponsor:
Eli Lilly and Company
Organization:
Eli Lilly and Company
Key Dates - Follows AllAPIJSON File Order
Start Date:
2003-03
Start Date Type:
None
Primary Completion Date:
None
Primary Completion Date Type:
None
Completion Date:
2003-10
Completion Date Type:
ACTUAL
First Submit Date:
2003-08-25
First Submit QC Date:
August 26 2003
Study First Post Date:
2003-08-27
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2007-12-03
Last Update Post Date:
2007-12-07
Last Update Post Date Type:
ESTIMATED